Skip to main content

Table 1 Initial set of objectives used for the inverse optimization

From: Elective breast radiotherapy including level I and II lymph nodes: A planning study with the humeral head as planning risk volume

Region of Interest

Type

Target (cGy)

Volume (%)

Weight

gEUD

PTVp-Lungs-Skin07a

Min DVH

4043

99

75

 

Max DVH

4470

1

1

 

Uniform Dose

4256

 

1

 

PTVn-Lungs-Skin07

Min DVH

4043

99

75

 

Max DVH

4430

1

1

 

Uniform Dose

4256

 

0.1

 

15_Ringtot_30b

Max Dose

4256

 

5

 

Lungs

Max EUD

700

 

1

1

Heart

Max EUD

700

 

1

1

For 6-field IMRT and VMAT with sparing of the humeral head:

10_Ring_10c

Max Dose

3900

 

1

 

hh+10d

Max Dose

3800

 

1

 
  1. aPTVp excluding the lungs and the skin + 7 mm
  2. bA ring at 15 mm distance from PTVtotal with a width of 30 mm, excluding the lungs and skin + 7 mm
  3. cA ring at 10 mm distance from PTVtotal with a width of 10 mm, with the caudal border 1 cm below the sternoclavicular joint and excluding the skin + 7 mm
  4. dHumeral head + 10 mm